Shares of Regeneron Pharmaceuticals Inc. REGN advanced 5.25% to $598.76 Wednesday, on what proved to be an all-around ...

Regeneron Pharmaceuticals Inc. closed 54.78% below its 52-week high of $1,211.20, which the company reached on August 27th.

The last upgrade for Regeneron Pharmaceuticals Inc happened on February 5, 2025 when Leerink Partners raised their price target to $834. Leerink Partners previously had a market perform for ...

The Regeneron Pharmaceuticals Inc.-Bond has a maturity date of 9/15/2050 and offers a coupon of 2.8000%. The payment of the coupon will take place 2,0 times per biannual on the 15.03.. At the ...